Radial vs Femoral for Rotational Atherectomy
angiographic findings, and procedural details. In-hospital death, major adverse cardiac and cerebrovascular events (MACCE), major bleeding, and access site complications are recorded. Data are collected according to a standard set of definitions and used for national audit and quality purposes, including public reporting of results. Any research department in the United Kingdom can apply to receive anonymized data from BCIS-NICOR for the purposes of research. Mortality tracking was provided by the Medical Research Information Service, using unique patient identifiers for all people registered with the National Health Service in England and Wales. Mortality tracking was unavailable for patients treated in Scotland or Northern Ireland; therefore, all procedures from these countries were not included. Institutional review board approval was not sought for this study as all data were anonymized and routinely collected as part of a national registry. All authors had full access to study data. The corresponding author takes responsibility for data integrity and analysis.
Study Population
All RA procedures in England or Wales between January 1, 2005, and March 31, 2014, were included. Patients who underwent RA via the right or left radial artery, or the right or left femoral artery, were included in the radial and femoral groups, respectively. Patients who had both radial and femoral arterial access sites used during the same procedure were excluded. Further exclusions were made for missing access site or 30-day mortality data.
Clinical Outcomes
The primary outcome of this study was 30-day mortality. The secondary outcomes were procedural success, in-hospital major bleeding, in-hospital major access site complications, in-hospital MACCE, and net adverse clinical events. Procedural success was recorded by the local operator. Major bleeding was defined as gastrointestinal, intracranial or retroperitoneal bleeding, pericardial bleeding causing tamponade, or any bleeding requiring blood or platelet transfusion or resulting in surgery. Major access site complications were defined as false aneurysm, retroperitoneal bleeding, major arterial dissection, or access site bleeding requiring blood or platelet transfusion, resulting in surgery or causing delayed discharge. MACCE was defined as a composite of 30-day mortality, in-hospital myocardial infarction, in-hospital target vessel revascularization, or in-hospital cerebrovascular event (stroke or transient ischemic attack). Net adverse clinical events was a composite of MACCE or in-hospital major bleeding. Complete revascularization was defined as zero vessels with obstructive stenosis post-PCI (left main stem ≥50%, or left anterior descending, circumflex or right coronary artery ≥75%), excluding cases with previous, unknown, or missing coronary artery bypass grafting status and residual obstructive stenosis, as BCIS does not record data for bypass graft patency.
Statistical Analysis
Data analysis was performed using Stata V14.1 (College Station, TX). Baseline data were compared for all eligible RA cases by radial and femoral access site. Missing data were dealt with by imputation through chained equations using the ice module in Stata. The degree of missing data is provided in the Data Supplement. We used the fraction of missing data to determine the number of imputed data sets. Baseline data were compared using χ 2 statistic for categorical variables and Kruskal-Wallis tests for continuous data. We estimated odds ratios (ORs) of study outcomes associated with access site using logistic regression models. The association between access site and outcome was first assessed with univariable logistic regression.
To allow appropriate multivariable adjustment, and to avoid the issue of overfitting, a 2-step process using propensity scores (PS) was used. First, we calculated the PS for each case, defining the dependent outcome as access site (radial or femoral). The PS was calculated, based on predefined clinically important covariables, available within the BCIS-NICOR database. The following variables were included in the PS model: age, sex, diabetes mellitus, hypertension, peripheral arterial disease, clinical presentation (stable or acute coronary syndrome), renal disease, hypercholesterolemia, largest balloon or stent diameter, stent length, number of vessels treated, artery treated, mechanical support, family history, previous coronary artery bypass grafting, use of glycoprotein inhibitor, deprivation quintile, cardiogenic shock, previous stroke or transient ischemic attack, use of DES, impaired left ventricular function, recent fibrinolysis, heart block requiring pacing, and year of procedure. The second step was to use the calculated PS as a covariable adjustment when assessing the association between radial (versus femoral) access and the study outcomes. Both univariable and multivariable (PS adjusted) logistic regression analyses are reported.
Results

Study Population
The flow of procedures in the study is shown in Figure 1 . A total of 729 268 PCI procedures were recorded by BCIS-NICOR in England and Wales between January 1, 2005, and March 31, 2014, of which 9712 (1.3%) involved RA. Eight thousand six hundred twenty-two RA procedures had used a single arterial access route (radial or femoral only) and were included in the analysis. There were 3069 RA procedures in the radial group and 5553 in the femoral group. There was a progressive increase in the use of radial access for RA throughout the study period ( Figure 2 ). Patients in the radial group were more likely to be male and treated for an acute coronary syndrome and had a lower incidence of previous coronary artery bypass grafting, renal disease, impaired left ventricular function, mechanical support, and temporary pacing (Table 1) . A higher rate of DES implantation was present in the radial group, reflecting the temporal shift in the use of radial access and DES use. Use of glycoprotein inhibitors and recent fibrinolysis was similar in both groups. The PS was calculated, and the C statistic was 0.68, indicating moderate to
WHAT IS KNOWN
• Rotational atherectomy (RA) is a valuable technique to treat calcified coronary lesions, which are increasingly prevalent in the elderly population.
• Randomized and observational studies have shown that radial access can improve morbidity and mortality in a variety of percutaneous coronary intervention populations, compared with femoral access.
• There are no large-scale studies examining the potential benefits and limitations of radial access in patients who undergo RA.
WHAT THE STUDY ADDS
• In this large real-world population undergoing RA, radial access was associated with equivalent 30-day mortality, with reduced major bleeding and access site complications, compared with femoral access.
• Improved safety of radial access for RA was not associated with compromised procedural success.
• Radial access should be considered as the preferred route for contemporary RA procedures.
good discrimination. The Hosmer-Lemeshow test was nonsignificant (P=0.32).
Relationship Between Access Site and 30-Day Mortality
Crude 30-day mortality was available for all patients and was 2.25% (194/8622) in the overall RA population, 2.18% (67/3069) in patients treated using radial access, and 2.29% (127/5553) in patients treated using femoral access (radial Tables 2 and 3 ). PS-adjusted logistic regression analysis was performed, accounting for differences in baseline clinical and procedural characteristics, and demonstrated no difference in 30-day mortality between radial and femoral groups (adjusted OR, 1.06; 95% CI, 0.77-1.46; P=0.71; Table 3 ). There was no difference in the time trend analysis of 30-day mortality, based on year of procedure (test of homogeneity [equal odds]; P=0.36).
Relationship Between Access Site and Secondary Outcomes
The crude rates of all prespecified study outcomes associated with access site are shown in Table 2 . Univariable and PSadjusted ORs using radial access as a predictor of study outcomes are shown in Table 3 The rate of complete revascularization was lower in patients treated using radial access (63.7% versus 66.8%; P=0.02); however, after PS adjustment, radial access was not an independent predictor of complete revascularization (adjusted OR, 0.92; 95% CI, 0.82-1.04; P=0.19).
Discussion
The BCIS-NICOR database effectively includes the totality of UK experience and outcomes related to the use of RA during the past decade. This observational study is the largest real-world comparison of patients undergoing RA via the radial or femoral arterial access route. We found no difference in 30-day mortality between radial and femoral groups. The absence of early mortality benefit associated with radial access in this study may reflect the predominantly stable population treated (approximately two thirds of procedures were for stable angina) and the very low incidence of RA performed in the primary or rescue PCI population (1.3% of cases in this study), both of which represent patient groups in whom the greatest mortality benefit with radial access has been demonstrated. However, radial access was associated with equivalent procedural success and a significantly lower incidence of in-hospital major bleeding and major access site complications, suggesting that radial access was the safer approach for RA. Importantly, no drawbacks of radial access were identified, despite the historical perceived advantages of femoral access.
Although no differences in survival were identified in our analysis, avoidance of vascular complications and bleeding is a major safety principle in modern PCI practice. In other studies, access site bleeding has been independently associated with an increase in mortality in patients undergoing PCI. 8, 9 Periprocedural major bleeding increases the risk of early and late mortality, 10, 11 and the adverse effect on survival is more pronounced in women, who have a higher risk of major bleeding than men. 12 Preprocedural risk stratification for bleeding may prompt implementation of bleeding avoidance strategies (including radial access) that can reduce the risk of major bleeding associated with PCI. 13 RA necessitates additional technical and training considerations compared with standard PCI, perhaps reflected in the relatively cautious adoption of radial access for this procedure in the United Kingdom. However, there is now widespread understanding that the technical challenges and procedurerelated complications related to the historical calcium debulking technique can be overcome in the great majority using a contemporary smaller (and usually single) burr approach. 3 A 6F guiding catheter can easily accommodate a 1.25 or 1.5 mm atherectomy burr and, in some cases, a 1.75 mm burr, depending on the internal catheter dimensions stated by the manufacturer and experience of the operator. Contemporary RA using burrs within this range (providing a burr/artery ratio of 0.5-0.6) will, in most cases, fulfill the main objective of plaque modification, by disrupting the continuity of concentric atherosclerotic calcium rings. If more extensive RA is required, 1.75 and 2.00 mm burrs can be accommodated using a 7F or 7.5F guiding catheter, which are compatible with most radial arteries, when inserted through a thin-walled hydrophilic sheath 14 or using a sheathless approach. 15 Radial access enables more patients with severe peripheral arterial disease or high bleeding risk, such as the elderly and patients presenting with acute coronary syndrome, to undergo RA safely and effectively. Given the safety and potential for routine early ambulation after radial procedures, day case elective RA may be feasible for some patients.
Advantages
Using the BCIS-NICOR data set, we have been able to study 8622 complex PCI cases involving RA during the past decade. It is highly unlikely that this number of RA procedures could be studied in a prospective randomized controlled manner. Thus, in the present PCI era, the current RA study provides a unique opportunity to study the effects of important procedural factors in this complex and increasingly common lesion subset. Mortality tracking was complete for all patients, and this provided a robust and unbiased primary end point. Although observational in nature, the positive findings of this study are consistent with the weight of evidence supporting radial access for PCI in patients with less complex lesion types.
Limitations
Our study has some limitations. Because of the retrospective observational nature of the study, differences may exist between groups which may affect the success and safety of each approach if examined in a prospective randomized manner. Hence, we cannot prove causality or exclude the possibility of residual confounding. It was not possible to assess whether both radial and femoral access were equally feasible for each individual case. In-hospital complications were recorded by individual institutions and may have been subject to under-reporting. The radial group differed from the femoral group with respect to several baseline variables; however, we performed multivariable logistic regression using PS, to adjust for potential confounding.
Certain data are unavailable in the BCIS-NICOR national data set and cannot be added retrospectively. Anatomic features, such as degree of calcification or tortuosity, were not recorded, and, if lesion complexity had been significantly different between groups, this may have influenced the relative procedural success and incidence of complications. Patient radiation exposure and procedure time were not known; however, we have previously reported no access site-dependent difference in these parameters for RA. 16 Data for arterial sheath, guiding catheter, or burr size were not recorded, although it is likely that these were smaller in the radial group. 16 Smaller caliber devices may contribute to improved safety with radial access, but without reduced procedural success, when using a contemporary RA technique.
Limitations in collected data fields and missing data are inherent in studies derived from large-scale national registries. 
Conclusions
We have demonstrated in a large all-comer UK population of 8622 patients undergoing RA that radial access was associated with equivalent 30-day mortality, procedural success, and MACCE, compared with femoral access. Radial access was associated with a lower risk of in-hospital major bleeding and major access site complications, thus supporting radial access as the default contemporary approach for most patients requiring RA.
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